Free Trial

Inhibikase Therapeutics (IKT) Income Statement & Balance Sheet

Inhibikase Therapeutics logo
$2.64
+0.11 (+4.35%)
(As of 11/1/2024 ET)

Inhibikase Therapeutics Income Statement, Balance Sheet and Cash Flow Statement



This page (NYSE:IKT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners